Novo Nordisk (NVO) shares are surging, up 51% in 2023. While the company recently raised its guidance due to Ozempic and Wegovy, mega demand for the stock is powering the surge.
Latest posts by Crypto Editor (see all)
- FP Markets Webinar for January 31: Explore TradingView with FP Markets Market Analyst Aaron Hill - January 18, 2024
- Crude Oil Price Forecast – Crude Oil Continues to Bounce Around - January 18, 2024
- AUD/USD Forecast – Australian Dollar Continues to Test Support - January 18, 2024
